Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma-Cell Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05739188
What this trial is testing

Safety and Efficacy of Anti-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China 18
Not applicableLooking for participantsNCT05334069
What this trial is testing

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more
Alliance for Clinical Trials in Oncology 2,000
Not applicableNot Yet RecruitingNCT06667583
What this trial is testing

5p15/ 9q22/ 15q22 Hyperdiploidy and Their Significance in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma, Neoplasms
Assiut University 40
Testing effectiveness (Phase 2)Study completedNCT00473590
What this trial is testing

Bevacizumab in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (AMBER)

Who this might be right for
Multiple Myeloma
Genentech, Inc. 102
Testing effectiveness (Phase 2)UnknownNCT00004903
What this trial is testing

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Robert H. Lurie Cancer Center
Early research (Phase 1)Study completedNCT00002818
What this trial is testing

High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaLymphoma+1 more
Virginia Commonwealth University 15
Testing effectiveness (Phase 2)Ended earlyNCT06655818
What this trial is testing

Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Dostarlimab (GSK4057190) in Participants With RRMM

Who this might be right for
Relapsed/Refractory Multiple Myeloma
GlaxoSmithKline 4
Testing effectiveness (Phase 2)Temporarily pausedNCT06876142
What this trial is testing

Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma

Who this might be right for
Multiple MyelomaRelapsed and/or Refractory Multiple Myeloma (RRMM)
National Cancer Institute (NCI) 54
Large-scale testing (Phase 3)Study completedNCT04939142
What this trial is testing

Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Antengene Corporation 154
Not applicableStudy completedNCT01006070
What this trial is testing

Health-Related Quality of Life (QOL), Physical and Respiratory Function in Patients With Myeloma Affecting the Spine

Who this might be right for
Multiple Myeloma
University of California, San Francisco 50
Testing effectiveness (Phase 2)Study completedNCT01245673
What this trial is testing

Combination Immunotherapy and Autologous Stem Cell Transplantation for Myeloma

Who this might be right for
Myeloma
University of Pennsylvania 28
Early research (Phase 1)Study completedNCT00083460
What this trial is testing

Study of Combination PS-341 and Thalidomide in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 86
Large-scale testing (Phase 3)Study completedNCT03158688
What this trial is testing

Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.

Who this might be right for
Relapsed Multiple MyelomaRefractory Multiple Myeloma
Amgen 466
Testing effectiveness (Phase 2)Study completedNCT03997968
What this trial is testing

CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors

Who this might be right for
MalignancyNon-hodgkin LymphomaMultiple Myeloma+12 more
Cyteir Therapeutics, Inc. 169
Not applicableLooking for participantsNCT07448779
What this trial is testing

Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment

Who this might be right for
AL AmyloidosisMGUSMultiple Myeloma+1 more
Fondazione IRCCS Policlinico San Matteo di Pavia 100
Testing effectiveness (Phase 2)UnknownNCT03977103
What this trial is testing

Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaMyeloproliferative Disorders+3 more
University Of Perugia 80
Testing effectiveness (Phase 2)Study completedNCT03964688
What this trial is testing

Effect of Vitamin C in Autologous Stem Cell Transplantations

Who this might be right for
Myeloma MultipleLymphoma
Maastricht University Medical Center 47
Post-approval studies (Phase 4)WithdrawnNCT01410929
What this trial is testing

Evaluation of Vertebral Compression Fracture Fixation With RF Kyphoplasty in Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaCompression Fracture of Vertebral Column
DFINE Inc.
Not applicableActive Not RecruitingNCT05271630
What this trial is testing

Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 69
Early research (Phase 1)Active Not RecruitingNCT02334865
What this trial is testing

SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy

Who this might be right for
Partial Response of Multiple Myeloma or Plasma Cell LeukemiaPlasma Cell Myeloma
Roswell Park Cancer Institute 18
Next Page